Analyst’s Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article. Seeking Alpha’s Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.
https://seekingalpha.com/article/4848125-robinhood-a-strong-business-at-a-difficult-entry-point?source=feed_all_articles
Tag Archives: alpha
Healthcare ETFs: I Prefer VHT’s Growth To XLV’s Stability
Analyst’s Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article. Seeking Alpha’s Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.
https://seekingalpha.com/article/4847823-healthcare-etfs-i-prefer-vht-growth-to-xlv-stability?source=feed_all_articles
Gilead Sciences: About To Break Out
Analyst’s Disclosure: I/we have a beneficial long position in the shares of GILD either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article. Seeking Alpha’s Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.
https://seekingalpha.com/article/4847402-gilead-sciences-about-to-break-out?source=feed_all_articles
ATRenew: The Market Is Ignoring The Improved Fundamentals
Analyst’s Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article. Seeking Alpha’s Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.
https://seekingalpha.com/article/4847372-atrenew-the-market-is-ignoring-the-improved-fundamentals?source=feed_all_articles
American Tower: Well-Covered 4% Dividend Potentially Attractive For Income-Oriented Investors (Rating Downgrade)
Analyst’s Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article. Seeking Alpha’s Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.
https://seekingalpha.com/article/4846280-american-tower-4-percent-dividend-potentially-attractive-for-income-oriented-investors?source=feed_all_articles
ams-OSRAM AG NPV (BR) (SUB RIGHT 06/12/2023) 2025 Q3 – Results – Earnings Call Presentation
Seeking Alpha’s transcripts team is responsible for the development of all of our transcript-related projects. We currently publish thousands of quarterly earnings calls per quarter on our site and are continuing to grow and expand our coverage. The purpose of this profile is to allow us to share with our readers new transcript-related developments. Thanks, SA Transcripts Team.
https://seekingalpha.com/article/4846756-ams-osram-ag-npv-br-sub-right-06-12-2023-2025-q3-results-earnings-call-presentation?source=feed_all_articles
Unusual Machines: Revenue Is Ready For Takeoff
Analyst’s Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article. Seeking Alpha’s Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.
https://seekingalpha.com/article/4844897-unusual-machines-revenue-is-readyfor-takeoff?source=feed_all_articles
FPA Global Equity ETF Q3 2025 Commentary
**FPA Global Equity ETF Q3 2025 Commentary — November 17, 2025**
*Published at 4:15 AM*
—
**Overview of Performance**
The FPA Global Equity ETF (FPAG) delivered a strong performance in the third quarter of 2025, with a net gain of **5.70%**. Over the trailing twelve months, the ETF’s return was nearly double, at **19.94%**.
In the past year, FPAG captured approximately **106.0%** of the MSCI ACWI’s return, highlighting its active management and selective investment approach.
—
**Top Performers and Sector Insights**
The ETF’s top five contributors added a combined **5.94%** to its quarterly return and **11.17%** to its twelve-month performance. Among these, **International Flavors & Fragrances** stands out as a leading producer of ingredients used across food, beverage, personal care, health, and household products industries.
Looking at sector allocations based on GICS classifications, the fund’s largest sectors as of this period are:
– **Communication Services:** 19.7%
– **Industrials:** 13.7%
– **Consumer Discretionary:** 12.4%
—
**Firm Background**
FPA is a Los Angeles-based institutional investment firm renowned for its disciplined value investing approach. The firm aims to generate superior long-term returns for its clients while prioritizing capital preservation.
—
**Contact and Additional Information**
For inquiries or further communication, please reach out through FPA’s official channels.
—
**Disclaimer:** This article was written by 31 followers. Please review all investment information carefully and consult with a financial advisor before making any investment decisions.
—
*Comments and discussions are encouraged. Stay informed with FPA’s latest insights and market analysis.*
https://seekingalpha.com/article/4844522-fpa-global-equity-etf-q3-2025-commentary?source=feed_all_articles
Conduit Holdings Limited 2025 Q3 – Results – Earnings Call Presentation
The Seeking Alpha Transcripts team is responsible for developing all of our transcript-related projects. Currently, we publish thousands of quarterly earnings calls each quarter on our site, and we are continuously growing and expanding our coverage.
The purpose of this profile is to share new transcript-related developments with our readers.
Thank you for your continued support,
SA Transcripts Team
https://seekingalpha.com/article/4844094-conduit-holdings-limited-2025-q3-results-earnings-call-presentation?source=feed_all_articles
Ginkgo Bioworks: Not There Yet
**Analyst’s Disclosure:**
I/we have no stock, option, or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.
Investors are always reminded that before making any investment, you should conduct your own proper due diligence on any name directly or indirectly mentioned in this article. Investors should also consider seeking advice from a broker or financial adviser before making any investment decisions.
Any material in this article should be considered general information and not relied on as a formal investment recommendation.
—
**Seeking Alpha’s Disclosure:**
Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor.
Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker, US investment adviser, or investment bank.
Our analysts are third-party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.
https://seekingalpha.com/article/4841702-ginkgo-bioworks-stock-q3-disappinting-revenue-growth-cash-burn-persists-sell?source=feed_all_articles
